Literature DB >> 21208577

Is DSM-IV bereavement exclusion for major depression relevant to treatment response? A case-control, prospective study.

Emmanuelle Corruble1, Bruno Falissard, Philip Gorwood.   

Abstract

OBJECTIVE: The aim of the bereavement exclusion criterion for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) major depressive episode (MDE) is to identify subjects with a modest, self-limited, "normal" depressive syndrome. One would therefore expect less severe depressive symptoms and a different and better outcome for bereaved subjects who were excluded from the diagnosis of MDE as compared to MDE controls. In a previous cross-sectional study, we have shown such expectations were not met. Herein, we further challenge the accuracy of the bereavement exclusion criterion regarding response to treatment.
METHOD: In a database of 12,615 subjects seeking treatment for depression, 1,138 (9.0%) individuals met DSM-IV MDE criteria except the bereavement exclusion criterion. This sample was matched for age, gender, educational level, and number of previous depressive episodes with 1,138 MDE patients. The bereavement exclusion and MDE groups were prospectively assessed for outcome after 6 weeks of treatment. Primary outcome measures included the number of DSM-IV MDE symptoms and the presence/absence of DSM-IV MDE Criterion A symptoms at follow-up.
RESULTS: The bereavement exclusion individuals had higher levels of DSM-IV MDE symptoms (P = .005) and self-rated depression (P < .0001) than MDE controls. Both groups had a similar 6-week outcome: 37.7% versus 39.9%, respectively, were responders to treatment, and 80.1% versus 82.2% no longer had the MDE DSM-IV symptom criteria at follow-up (P = .33).
CONCLUSIONS: The DSM-IV bereavement exclusion for MDE is inadequate according to response to treatment, at least in this sample of individuals seeking treatment for depressive symptoms. It is proposed that bereavement, just as any stressful event, could be noted but without its affecting the treatment decision. © Copyright 2011 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21208577     DOI: 10.4088/JCP.09m05681blu

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  9 in total

1.  Fallacious reasoning in the argument to eliminate the major depression bereavement exclusion in DSM-5.

Authors:  Jerome Wakefield; Michael First
Journal:  World Psychiatry       Date:  2012-10       Impact factor: 49.548

2.  The bereavement exclusion may not be applicable in real world settings.

Authors:  Emmanuelle Corruble
Journal:  World Psychiatry       Date:  2012-10       Impact factor: 49.548

Review 3.  Bereavement: course, consequences, and care.

Authors:  Sidney Zisook; Alana Iglewicz; Julie Avanzino; Jeanne Maglione; Danielle Glorioso; Samuel Zetumer; Kathryn Seay; Ipsit Vahia; Ilanit Young; Barry Lebowitz; Ronald Pies; Charles Reynolds; Naomi Simon; M Katherine Shear
Journal:  Curr Psychiatry Rep       Date:  2014-10       Impact factor: 5.285

4.  Validity of the bereavement exclusion to major depression: does the empirical evidence support the proposal to eliminate the exclusion in DSM-5?

Authors:  Jerome C Wakefield; Michael B First
Journal:  World Psychiatry       Date:  2012-02       Impact factor: 49.548

5.  Distinguishing Bereavement from Depression in DSM-5: Evidence from Longitudinal Epidemiologic Surveys.

Authors:  Diana Paksarian; Ramin Mojtabai
Journal:  Psychiatr Ann       Date:  2013-06

Review 6.  The removal of the bereavement exclusion in the DSM-5: exploring the evidence.

Authors:  Alana Iglewicz; Kathryn Seay; Samuel David Zetumer; Sidney Zisook
Journal:  Curr Psychiatry Rep       Date:  2013-11       Impact factor: 5.285

Review 7.  Suicide bereavement and complicated grief.

Authors:  Ilanit Tal Young; Alana Iglewicz; Danielle Glorioso; Nicole Lanouette; Kathryn Seay; Manjusha Ilapakurti; Sidney Zisook
Journal:  Dialogues Clin Neurosci       Date:  2012-06       Impact factor: 5.986

8.  Geriatric Psychiatry: What's in a Name, and Five Concerns about DSM-5.

Authors:  Mark J Rapoport
Journal:  Can Geriatr J       Date:  2014-12-02

9.  High heterogeneity and low reliability in the diagnosis of major depression will impair the development of new drugs.

Authors:  Samuel M Lieblich; David J Castle; Christos Pantelis; Malcolm Hopwood; Allan Hunter Young; Ian P Everall
Journal:  BJPsych Open       Date:  2015-11-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.